Skip to main content
Erschienen in: Sleep and Breathing 4/2019

14.02.2019 | Sleep Breathing Physiology and Disorders • Original Article

The reduction of apnea–hypopnea duration ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in a rat model of obstructive sleep apnea

verfasst von: Hao Wu, Qianwen Lv, Huina Zhang, Yanwen Qin, Fang Fang, Haili Sun, Yongxiang Wei

Erschienen in: Sleep and Breathing | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate the effect of obstructive sleep apnea (OSA) and apnea–hypopnea duration on endothelial, ventricular function, blood pressure, and inflammation in a rat model.

Methods

We established a novel rat model of OSA. Wistar rats were randomized to six groups according to 4-week different treatments: (1) OSA (apnea for 60 s in a 90-s window of breathing [60 s/90 s] with anesthesia), (2) OSA 30 s/90 s with anesthesia, (3) partial recovery (60 s/90 s for 2 weeks, followed by 15 s/90 s for 2 weeks with anesthesia), (4) complete recovery (60 s/90 s for 2 weeks with anesthesia, and then normal breathing for 2 weeks), (5) sham (normal breathing in the device with anesthesia), and (6) control group (normal breathing, normal cage, no anesthesia). We recorded blood pressure, endothelial function, left ventricular function, and inflammation at different time points.

Results

Vascular inflammation and endothelial dysfunction occurred in OSA models. More systemic inflammatory and endothelial dysfunction were observed in longer apnea–hypopnea duration group and they were reversed in both partial and complete recovery groups. Left ventricular weight/body weight ratio was significantly higher in the OSA (60s/90s) group than complete recovery, sham, and control groups, which remained unchanged in partial recovery group (p < 0.05).

Conclusions

Longer apnea–hypopnea duration is related to more systemic inflammatory and endothelial dysfunction, and hypertension and cardiac remodeling. These can be reversed after a period of recovery, which indicates that time parameters for assessing OSA, such as apnea–hypopnea duration, should be considered instead of apnea–hypopnea index only.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRef Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRef
2.
Zurück zum Zitat Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, Malhotra A, Martinez-Garcia MA, Mehra R, Pack AI, Polotsky VY, Redline S, Somers VK (2017) Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 69:841–858CrossRef Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, Malhotra A, Martinez-Garcia MA, Mehra R, Pack AI, Polotsky VY, Redline S, Somers VK (2017) Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 69:841–858CrossRef
3.
Zurück zum Zitat Anu MM, Antti K, Mikko H, Salla K, Taina H, Pekka T et al (2013) The severity of individual obstruction events is related to increased mortality rate in severe obstructive sleep apnea. J Sleep Res 22:663–669CrossRef Anu MM, Antti K, Mikko H, Salla K, Taina H, Pekka T et al (2013) The severity of individual obstruction events is related to increased mortality rate in severe obstructive sleep apnea. J Sleep Res 22:663–669CrossRef
4.
Zurück zum Zitat Kulkas A, Tiihonen P, Julkunen P, Mervaala E, Töyräs J (2013) Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea–hypopnea index. Med Biol Eng Comput 51:697–708CrossRef Kulkas A, Tiihonen P, Julkunen P, Mervaala E, Töyräs J (2013) Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea–hypopnea index. Med Biol Eng Comput 51:697–708CrossRef
5.
Zurück zum Zitat Seif F, Patel SR, Walia H, Rueschman M, Bhatt DL, Gottlieb DJ, Lewis EF, Patil SP, Punjabi NM, Babineau DC, Redline S, Mehra R (2013) Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res 22:443–451CrossRef Seif F, Patel SR, Walia H, Rueschman M, Bhatt DL, Gottlieb DJ, Lewis EF, Patil SP, Punjabi NM, Babineau DC, Redline S, Mehra R (2013) Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res 22:443–451CrossRef
6.
Zurück zum Zitat Alex R, Manchikatla S, Machiraju K, Altuwaijri E, Watenpaugh DE, Zhang R et al (2014) Effect of apnea duration on apnea induced variations in cerebral blood flow velocity and arterial blood pressure. Eng Med Biol Soc 270–3 Alex R, Manchikatla S, Machiraju K, Altuwaijri E, Watenpaugh DE, Zhang R et al (2014) Effect of apnea duration on apnea induced variations in cerebral blood flow velocity and arterial blood pressure. Eng Med Biol Soc 270–3
7.
Zurück zum Zitat Li HY, Wang PC, Chen YP, Lee LA, Fang TJ, Lin HC (2011) Critical appraisal and meta-analysis of nasal surgery for obstructive sleep apnea. Am J Rhinol Allergy 25:45–49CrossRef Li HY, Wang PC, Chen YP, Lee LA, Fang TJ, Lin HC (2011) Critical appraisal and meta-analysis of nasal surgery for obstructive sleep apnea. Am J Rhinol Allergy 25:45–49CrossRef
8.
Zurück zum Zitat Ishii L, Roxbury C, Godoy A, Ishman S, Ishii M (2015) Does nasal surgery improve OSA in patients with nasal obstruction and OSA? A meta-analysis. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck. Surgery 153:326–333 Ishii L, Roxbury C, Godoy A, Ishman S, Ishii M (2015) Does nasal surgery improve OSA in patients with nasal obstruction and OSA? A meta-analysis. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck. Surgery 153:326–333
9.
Zurück zum Zitat Sufioğlu M, Ozmen OA, Kasapoglu F, Demir UL, Ursavas A, Erişen L, Onart S (2012) The efficacy of nasal surgery in obstructive sleep apnea syndrome: a prospective clinical study. Eur Arch Oto-Rhino-L 269:487–494CrossRef Sufioğlu M, Ozmen OA, Kasapoglu F, Demir UL, Ursavas A, Erişen L, Onart S (2012) The efficacy of nasal surgery in obstructive sleep apnea syndrome: a prospective clinical study. Eur Arch Oto-Rhino-L 269:487–494CrossRef
10.
Zurück zum Zitat Bostanci A, Bozkurt S, Turhan M (2015) The relationship between the duration of obstructive respiratory events and outcomes of multilevel upper airway surgery in patients with obstructive sleep apnea. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck. Surgery 273:1–7 Bostanci A, Bozkurt S, Turhan M (2015) The relationship between the duration of obstructive respiratory events and outcomes of multilevel upper airway surgery in patients with obstructive sleep apnea. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck. Surgery 273:1–7
11.
Zurück zum Zitat Asha’Ari ZA, Rahman JA, Mohamed AH, Abdullah K, Leman WI (2017) Association between severity of obstructive sleep apnea and number and sites of upper airway operations with surgery complications. JAMA Otolaryngol Head Neck Surg 143:239–246CrossRef Asha’Ari ZA, Rahman JA, Mohamed AH, Abdullah K, Leman WI (2017) Association between severity of obstructive sleep apnea and number and sites of upper airway operations with surgery complications. JAMA Otolaryngol Head Neck Surg 143:239–246CrossRef
12.
Zurück zum Zitat Pang KP, Pang EB, Pang KA, Vicini C, Chan YH Rotenberg BW (2017) Upper airway surgery for obstructive sleep apnea reduces blood pressure. Laryngoscope 128(9464)CrossRef Pang KP, Pang EB, Pang KA, Vicini C, Chan YH Rotenberg BW (2017) Upper airway surgery for obstructive sleep apnea reduces blood pressure. Laryngoscope 128(9464)CrossRef
13.
Zurück zum Zitat Wu H, Zhan X, Zhao M, Wei Y (2016) Mean apnea-hypopnea duration (but not apnea-hypopnea index) is associated with worse hypertension in patients with obstructive sleep apnea. Medicine (Baltimore) 95:e5493CrossRef Wu H, Zhan X, Zhao M, Wei Y (2016) Mean apnea-hypopnea duration (but not apnea-hypopnea index) is associated with worse hypertension in patients with obstructive sleep apnea. Medicine (Baltimore) 95:e5493CrossRef
14.
Zurück zum Zitat Lee KZ, Hsu SH (2017) Compensatory function of the diaphragm following high cervical hemisection in the rat. J Neurotraum 34:2634–2644CrossRef Lee KZ, Hsu SH (2017) Compensatory function of the diaphragm following high cervical hemisection in the rat. J Neurotraum 34:2634–2644CrossRef
15.
Zurück zum Zitat Zhang H, Liu J, Qu D, Wang L, Luo JY, Lau CW, Liu P, Gao Z, Tipoe GL, Lee HK, Ng CF, Ma RCW, Yao X, Huang Y (2016) Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2. Diabetes 65:1196–1207CrossRef Zhang H, Liu J, Qu D, Wang L, Luo JY, Lau CW, Liu P, Gao Z, Tipoe GL, Lee HK, Ng CF, Ma RCW, Yao X, Huang Y (2016) Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2. Diabetes 65:1196–1207CrossRef
16.
Zurück zum Zitat Cunningham JT, Knight WD, Mifflin SW, Nestler EJ (2012) An essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. Hypertension 60:179–187CrossRef Cunningham JT, Knight WD, Mifflin SW, Nestler EJ (2012) An essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. Hypertension 60:179–187CrossRef
17.
Zurück zum Zitat Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR, O’Donnell CP (2001) A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91:2758–2766CrossRef Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR, O’Donnell CP (2001) A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91:2758–2766CrossRef
18.
Zurück zum Zitat Iwasaki YK, Kato T, Xiong F, Shi YF, Naud P, Maguy A, Mizuno K, Tardif JC, Comtois P, Nattel S (2014) Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64:2013–2023CrossRef Iwasaki YK, Kato T, Xiong F, Shi YF, Naud P, Maguy A, Mizuno K, Tardif JC, Comtois P, Nattel S (2014) Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64:2013–2023CrossRef
19.
Zurück zum Zitat Almendros I, Farré R, Planas AM, Torres M, Bonsignore MR, Navajas D, Montserrat JM (2011) Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep 34:1127–1133CrossRef Almendros I, Farré R, Planas AM, Torres M, Bonsignore MR, Navajas D, Montserrat JM (2011) Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep 34:1127–1133CrossRef
20.
Zurück zum Zitat Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9:1003PubMedPubMedCentral Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9:1003PubMedPubMedCentral
21.
Zurück zum Zitat Vitulano N, Di MBA, Re A, Riccioni G, Perna F, Mormile F et al (2013) Obstructive sleep apnea and heart disease: the biomarkers point of view. Front Biosci S5:588–599CrossRef Vitulano N, Di MBA, Re A, Riccioni G, Perna F, Mormile F et al (2013) Obstructive sleep apnea and heart disease: the biomarkers point of view. Front Biosci S5:588–599CrossRef
22.
Zurück zum Zitat Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRef Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRef
23.
Zurück zum Zitat Lindsay MM, Maxwell PDunn FG (2002) TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136–141CrossRef Lindsay MM, Maxwell PDunn FG (2002) TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136–141CrossRef
24.
Zurück zum Zitat Parati G, Ochoa JE, Bilo G, Mattaliano P, Salvi P, Kario K et al (2014) Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res 37:601–613CrossRef Parati G, Ochoa JE, Bilo G, Mattaliano P, Salvi P, Kario K et al (2014) Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res 37:601–613CrossRef
25.
Zurück zum Zitat Takawale A, Zhang P, Patel VB, Wang X, Oudit G, Kassiri Z (2017) Tissue inhibitor of matrix metalloproteinase-1 promotes myocardial fibrosis by mediating CD63-integrin β1 interaction. Hypertension Takawale A, Zhang P, Patel VB, Wang X, Oudit G, Kassiri Z (2017) Tissue inhibitor of matrix metalloproteinase-1 promotes myocardial fibrosis by mediating CD63-integrin β1 interaction. Hypertension
26.
Zurück zum Zitat Marchesi C, Dentali F, Nicolini E, Maresca AM, Tayebjee MH, Franz M, Guasti L, Venco A, Schiffrin EL, Lip GYH, Grandi AM (2012) Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis. J Hypertens 30:3–16CrossRef Marchesi C, Dentali F, Nicolini E, Maresca AM, Tayebjee MH, Franz M, Guasti L, Venco A, Schiffrin EL, Lip GYH, Grandi AM (2012) Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis. J Hypertens 30:3–16CrossRef
27.
Zurück zum Zitat Dhingra R, Pencina MJ, Schrader P, Wang TJ, Levy D, Pencina K, Siwik DA, Colucci WS, Benjamin EJ, Vasan RS (2009) Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community. Circulation 119:1101–1107CrossRef Dhingra R, Pencina MJ, Schrader P, Wang TJ, Levy D, Pencina K, Siwik DA, Colucci WS, Benjamin EJ, Vasan RS (2009) Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community. Circulation 119:1101–1107CrossRef
28.
Zurück zum Zitat Ferretti G, Bacchetti T, Banach M, Simentalmendía LE, Sahebkar A (2016) Impact of statin therapy on plasma MMP-3, MMP-9, and TIMP-1 concentrations. Angiology 2016293031507 Ferretti G, Bacchetti T, Banach M, Simentalmendía LE, Sahebkar A (2016) Impact of statin therapy on plasma MMP-3, MMP-9, and TIMP-1 concentrations. Angiology 2016293031507
29.
Zurück zum Zitat Lambert E, Dassé E, Haye B, Petitfrère E (2004) TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187–198CrossRef Lambert E, Dassé E, Haye B, Petitfrère E (2004) TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187–198CrossRef
Metadaten
Titel
The reduction of apnea–hypopnea duration ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in a rat model of obstructive sleep apnea
verfasst von
Hao Wu
Qianwen Lv
Huina Zhang
Yanwen Qin
Fang Fang
Haili Sun
Yongxiang Wei
Publikationsdatum
14.02.2019
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 4/2019
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-019-01798-3

Weitere Artikel der Ausgabe 4/2019

Sleep and Breathing 4/2019 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

The correct measurement of oxygen saturation at high altitude

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.